Neurocrine Biosciences: Q1 Earnings Insights

Neurocrine Biosciences NBIX reported its Q1 earnings results on Wednesday, May 3, 2023 at 07:30 AM.

Here's what investors need to know about the announcement.

Neurocrine Biosciences missed estimated earnings by 492.31%, reporting an EPS of $-0.51 versus an estimate of $0.13.

Revenue was up $109.80 million from the same period last year.

Last quarter the company beat on EPS by $0.1 which was followed by a 1.14% drop in the share price the next day.

Here's a look at Neurocrine Biosciences's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	1.14	0.80	0.59	0.34
EPS Actual	1.24	1.08	0.84	0.30
Revenue Estimate	409.09M	376.50M	341.31M	303.40M
Revenue Actual	412.00M	387.90M	378.20M	310.60M

To track all earnings releases for Neurocrine Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar